Filament Health Corp
Filament Health Corp. operates as a clinical-stage natural psychedelic drug development company in Canada. The company's leading drug candidates comprises PEX010 oral psilocybin, PEX020 oral psilocin, and PEX030 sublingual psilocin. It also develops AEX010 ayahuasca, which is in preclinical stage; and AEX020 monoamine oxidase inhibitor and is in preclinical stage. In addition, the company provide… Read more
Market Cap & Net Worth: Filament Health Corp (FLHLF)
Filament Health Corp (OTCQB:FLHLF) has a market capitalization of $5.10 Million ($5.10 Million) as of March 19, 2026. Listed on the OTCQB stock exchange, this USA-based company holds position #34559 globally and #11276 in its home market, demonstrating a -8.45% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Filament Health Corp's stock price $0.02 by its total outstanding shares 261794000 (261.79 Million).
Filament Health Corp Market Cap History: 2021 to 2025
Filament Health Corp's market capitalization history from 2021 to 2025. Data shows change from $59.48 Million to $5.10 Million (-53.39% CAGR).
Filament Health Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Filament Health Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
16.73x
Filament Health Corp's market cap is 16.73 times its annual revenue
1.02x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $59.48 Million | $162.50K | -$9.25 Million | 366.03x | N/A |
| 2022 | $16.44 Million | $364.50K | -$16.47 Million | 45.10x | N/A |
| 2023 | $14.16 Million | $2.13 Million | -$5.32 Million | 6.65x | N/A |
| 2024 | $10.31 Million | $616.68K | -$4.97 Million | 16.73x | N/A |
Competitor Companies of FLHLF by Market Capitalization
Companies near Filament Health Corp in the global market cap rankings as of March 19, 2026.
Key companies related to Filament Health Corp by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Filament Health Corp Historical Marketcap From 2021 to 2025
Between 2021 and today, Filament Health Corp's market cap moved from $59.48 Million to $ 5.10 Million, with a yearly change of -53.39%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $5.10 Million | -50.51% |
| 2024 | $10.31 Million | -27.17% |
| 2023 | $14.16 Million | -13.85% |
| 2022 | $16.44 Million | -72.36% |
| 2021 | $59.48 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Filament Health Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $5.10 Million USD |
| MoneyControl | $5.10 Million USD |
| MarketWatch | $5.10 Million USD |
| marketcap.company | $5.10 Million USD |
| Reuters | $5.10 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.